Newron Pharmaceuticals S.p.A. Stock
Stocks
NWRN
IT0004147952
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.38 CHF | -1.73% |
|
-3.56% | -52.29% |
| 07-03 | Newron Pharmaceuticals to Make Changes to Phase 3 Trial of Schizophrenia Treatment | MT |
| 05-05 | Edison Is Not Overly Concerned About a Trial Suspension |  |
| Market Cap | 256M 292M 237M 218M 412M 28.2B 418M 2.83B 1.11B 13.8B 1.1B 1.07B 47.5B | P/E 2026 * |
-9.07x | P/E 2027 * | 33.3x |
|---|---|---|---|---|---|
| Enterprise Value | 295M 336M 273M 251M 474M 32.46B 481M 3.26B 1.28B 15.88B 1.26B 1.24B 54.67B | EV / Sales 2026 * |
27.2x | EV / Sales 2027 * | 6.04x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Newron Pharmaceuticals S.p.A.
| 1 day | -1.73% | ||
| 1 week | -3.56% | ||
| Current month | -12.73% | ||
| 1 month | -6.72% | ||
| 3 months | -30.78% | ||
| 6 months | -51.98% | ||
| Current year | -52.29% |
| 1 week | 11.24 |  | 12 |
| 1 month | 11.24 | | 13.18 |
| Current year | 11.24 | | 31.85 |
| 1 year | 6.5 | | 31.85 |
| 3 years | 4.09 | | 31.85 |
| 5 years | 1.01 | | 31.85 |
| 10 years | 0.9 | | 31.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stefan Weber
CEO | Chief Executive Officer | 62 | 2012-05-14 |
Roberto Galli
DFI | Director of Finance/CFO | - | 2011-12-31 |
Filippo Moriggia
COO | Chief Operating Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stefan Weber
BRD | Director/Board Member | 62 | 2012-05-14 |
Gillian Dines
BRD | Director/Board Member | - | 2023-03-31 |
Margarita Chavez
BRD | Director/Board Member | - | 2024-04-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/3/25 | Sell | 5,465 | 0.0274% | |||
| 12/3/25 | Fiscal year | Founder | 5,465 | 0.0274% | ||
| 11/27/25 | Fiscal year | Founder | 14,567 | 0.0730% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.73% | -3.56% | +67.60% | +107.66% | 299M | |
| -0.49% | -3.58% | -0.84% | +2.13% | 49.18B | |
| -3.10% | -3.47% | +370.99% | +567.62% | 39.58B | |
| -0.46% | +3.98% | +5.44% | +60.79% | 34.69B | |
| -1.14% | -1.90% | +26.94% | -9.56% | 34.42B | |
| -1.82% | -1.48% | +0.52% | +32.02% | 27.11B | |
| -3.54% | -6.91% | - | - | 16.21B | |
| -1.82% | -1.91% | +69.28% | +112.51% | 15.36B | |
| +1.17% | +3.10% | +15.87% | +16.79% | 14.05B | |
| -2.25% | -0.92% | +15.77% | -32.78% | 13.02B | |
| Average | -1.52% | -0.34% | +63.51% | +95.24% | 24.39B | |
| Weighted average by Cap. | -1.44% | -0.38% | +75.90% | +117.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.84M 12.37M 10.03M 9.22M 17.43M 1.19B 17.69M 120M 46.93M 584M 46.45M 45.44M 2.01B | 44.83M 51.16M 41.45M 38.11M 72.05M 4.94B 73.13M 496M 194M 2.41B 192M 188M 8.31B |
| Net income | -31.17M -35.58M -28.83M -26.5M -50.1M -3.43B -50.86M -345M -135M -1.68B -134M -131M -5.78B | 5.02M 5.73M 4.64M 4.27M 8.07M 553M 8.19M 55.52M 21.74M 271M 21.52M 21.05M 931M |
| Net Debt | 38.68M 44.15M 35.77M 32.88M 62.17M 4.26B 63.11M 428M 167M 2.08B 166M 162M 7.17B | 14.72M 16.79M 13.61M 12.51M 23.65M 1.62B 24.01M 163M 63.69M 793M 63.04M 61.67M 2.73B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | CHF 11.38 | -1.73% | 24,326 |
| 26-07-17 | CHF 11.58 | +1.40% | 28,715 |
| 26-07-16 | CHF 11.42 | -0.35% | 59,910 |
| 26-07-15 | CHF 11.46 | -1.04% | 78,260 |
| 26-07-14 | CHF 11.58 | -1.36% | 26,226 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NWRN Stock
Select your edition
All financial news and data tailored to specific country editions
